Regencell Bioscience Holdings cash flow statement data for the quarter ended Jun 2025. This cash flow statement covers 3 quarters of results from Jun 2022 through Jun 2025, standardized by Business Quant from the company’s SEC filings.
| Cash Flow Statement | Jun2022 | Jun2023 | Jun2025 |
|---|---|---|---|
| Operating Activities | |||
| Share-based Compensation | 0.80M | 24.49M | |
| Financing Activities | |||
| Change in Capital Stock | |||
| Shares Issued | 0.30M | ||
| Net Shares Issued and Repurchased | 0.18M | 4.77M |